PDF herunterladen
Thromb Haemost 1999; 82(S 01): 53-59
DOI: 10.1055/s-0037-1615553
Commentaries
Schattauer GmbH

Unstable Angina in 1998

P. R. Lichtlen
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
14. Dezember 2017 (online)

    Lizenzen und Reprints

Summary

Unstable angina (UA) and non-Q-wave myocardial infarction (NQWMI) are acute coronary syndromes with repeated, severe ischemic events of short duration. These events are mainly due to a rapid decrease in coronary blood flow, and to a rapid, reversible reduction of the arterial lumen in localized areas. Episodes often are a mixture of thrombus formation due to platelet aggregation and localized spasm, leading to vasoconstriction. Due to the short interval (minutes) of ischemic events, usually no or minimal irreversible myocardial damage takes place.

The main goal of treatment is to prevent progression of this unstable situtation into a myocardial infarction. In the majority of cases, this is possible with adequate treatment of vasodilatory substances like nitrates, long-acting dihydropyridines like amlodipine and betablockers. In addition heparin and particular antiaggregatory drugs inhibiting platelet activation by blocking the GPIIb/IIIa receptor, the common pathway for platelet aggregation, are applied to prevent thrombus formation. This, in the majority of cases allows a passivation of the acute situtation, leaving time to undertake possible further steps as coronary angiography, eventually followed by PTCA of the culprit lesion or, in advanced cases of CAD, by CABG with complete revascularization.

Key words

Myocardial infarction - plaque passivation - coronary angiography - PTCA - CAD - CABG
 

  • References

  • 1 Andreotti F, Pasceri V, Hacket DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. NEJM 1996; 334: 7-12.
    CrossrefPubMedGoogle Scholar
  • 2 Braunwald E. Unstable angina: Classification. Circ 1989; 80: 410-4.
    CrossrefPubMedGoogle Scholar
  • 3 Braunwald E, Jones RH, Mark DB, Brown J. et al. Diagnosing and managing unstable angina. Circ 1994; 90: 613-22.
    CrossrefPubMedGoogle Scholar
  • 4 Burke AP, Forb A, Malcolm GT. et al. Coronary risk factors and plaque morphology in men with coronary artery diesase who died suddenly. NEJM 1997; 336: 1276-81.
    CrossrefPubMedGoogle Scholar
  • 5 Bogaty P, Hacket D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circ 1994; 90: 5-11.
    CrossrefPubMedGoogle Scholar
  • 6 Balsano F, Rizzon P, Violi F. et al. and the studio della ticlopidina nell' angina instabile group. Antiplatelet treatment with ticlopidine in unstable angina: a controlled multicenter clinical trial. Circ 1990; 82: 17-26.
    CrossrefPubMedGoogle Scholar
  • 7 Boher S, Reicher-Reiss H, Abinader E. et al. Prognostic significance of angina pectoris preceding the occurrence of a first, acute myocardial infarction in 4166 concecutive hospitalized patients. Am Heart J 1992; 123: 1481-6.
    CrossrefPubMedGoogle Scholar
  • 8 Cairns J, Theroux P, Armstrong P. et al. Unstable angina: report from a Canadian expert round table. Canad J Cardiol 1996; 1279-92.
    PubMedGoogle Scholar
  • 9 Cairns JA, Gent M, Singer J. et al. Aspirin, sulfinpyrazon or both in unstable angina. NEJM 1985; 313: 1369-75.
    CrossrefPubMedGoogle Scholar
  • 10 Califf R. for the PURSUIT Investigators. Platelet IIb/IIIa: Receptor suppression in using integrilin trial. Presented at the ESC Meeting, Stockholm. August 25 1997
    PubMedGoogle Scholar
  • 11 The CAPTURE Investigators. Randomized, placebo-controlled trial of abciximab before and during coronary interventions in refractory unstable angina: the CAPTURE trial. Lancet 1997; 349: 1429-35.
    CrossrefPubMedGoogle Scholar
  • 12 Clark R, Mayo G, Price P, Fitzgerald GF. Suppression of TXA2 but not of systemic prostacyclin by controlled release aspirin. NEJM 1991; 325: 1137-41.
    CrossrefPubMedGoogle Scholar
  • 13 Cohen M, Adams PC, Parry G. et al. Antithrombotic therapy in unstable rest angina and non-Q-wave myocardial infarction in nonprior aspirin users. Circ 1994; 89: 81-8.
    CrossrefPubMedGoogle Scholar
  • 14 Cohen M, Demers C, Gurfinkel EP. et al. For the efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group. Low molecular weight heparin versus unfractionated heparin in unstable angina and non-Q-wave myocardial infarctions. NEJM 1997; 337: 447-52.
    CrossrefPubMedGoogle Scholar
  • 15 Colber BS, Anderson K, Weisman HF. New platelet agents: Platelet GPIIb/IIIa antagonists. Thromb Haemost 1995; 74: 302-8.
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 16 Davies MJ, Thomas AC. Plaque Assuring - the cause of acute myocardial infarction, sudden ischemic death and crecendo angina. Br Heart J 1985; 53: 363-73.
    CrossrefPubMedGoogle Scholar
  • 17 de Feyter PJ, Ozahi P, Battista J. et al. Ischemia related lesions characteristics in patients with stable or unstable angina: a study with intracoronary angioscopy and ultrasound. Circ 1995; 1408-13.
    PubMedGoogle Scholar
  • 18 The EPIC investigators. Use of monoclonal antibody directed against the platelet GPIIb/IIIa receptor in high risk coronary angioplasty. NEJM 1994; 330: 956-61.
    CrossrefPubMedGoogle Scholar
  • 19 The EPILOG Investigators. Platelet GPIIb/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularization. NEJM 1997; 336: 1689-96.
    CrossrefPubMedGoogle Scholar
  • 20 Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circ 1995; 92: 657-71.
    CrossrefPubMedGoogle Scholar
  • 21 The FRISC, study group. Low-molecular weight heparin during instability in coronary artery disease. Lancet 1996; 347: 561-8.
    CrossrefPubMedGoogle Scholar
  • 22 Fuster V, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. NEJM 1992; 326: 242-50 310-8.
    CrossrefPubMedGoogle Scholar
  • 23 Fuster V. Lewis A Connor Memorial Lecture: Mechanisms leading to myocardial infarctions; insights from studies of vascular biology. Circ 1994; 90: 2126-46.
    CrossrefPubMedGoogle Scholar
  • 24 The GLOBAL use of strategies to open occluded coronary arteries (GUSTO) IIa investigators. Randomized trial of intravenous heparin versus recombinent hirudin for acute coronary syndromes. Circ 1994; 90: 1631-67.
    CrossrefPubMedGoogle Scholar
  • 25 Gottlieb SO, Weisfeldt ML, Ouyang P. et al. Silent ischemia as a marker for early unfavourable outcomes in patients with unstable angina. NEJM 1986; 314: 1214-9.
    CrossrefPubMedGoogle Scholar
  • 26 Hirai T, Fujita M, Yamanishi K, Ohno A, Miwa K, Sasayama S. Significance of preinfarction angina for preservation of LV function in acute myocardial infarction. Am Heart J 1992; 124: 19-23.
    CrossrefPubMedGoogle Scholar
  • 27 Hultgren HN, Pfeiffer JF, Angel WW. et al. Unstable angina: comparison of medical and surgical patients. Am J Cardiol 1977; 39: 734-40.
    CrossrefPubMedGoogle Scholar
  • 28 Karlson BW, Herlitz J, Petterson P. et al. One year prognosis in patients with a history of unstable angina pectoris. Clin Cardiol 1993; 16: 397-402.
    CrossrefPubMedGoogle Scholar
  • 29 Katus A, Remppis A, Neumann FJ. et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circ 1991; 83: 902-12.
    CrossrefPubMedGoogle Scholar
  • 30 Kloner RA, Shook T, Przyklenk K. et al. For the TIMI-4 Investigators. Previous angina alters inhospital outcome in TIMI-4: A clinical correlate to preconditioning. Circ 1995; 81: 291-7.
    PubMedGoogle Scholar
  • 31 Kroll MH, Harris TS, Moake JL. et al. Von Willebrand factor binding to platelet GPIb initiates signals for platelet activation. J Clin Invest 1991; 88: 1568-73.
    CrossrefPubMedGoogle Scholar
  • 32 Lefkovits J, Plow EF, Topol EJ. Platelet GP IIb/IIIa receptors in cardiovascular medicine. NEJM 1995; 332: 1553-9.
    CrossrefPubMedGoogle Scholar
  • 33 Lewis HD, Davis JW, Archibald DG. et al. Protective effects of aspirin against myocardial infarction and death in men with unstable angina: Results of a Vet. Adm. Coop. Study. NEJM 1983; 309: 396-403.
    CrossrefPubMedGoogle Scholar
  • 34 Libby P. Molecular basis of the acute coronary syndromes. Circ 1995; 91: 2844-50.
    CrossrefPubMedGoogle Scholar
  • 35 Luchi RJ, Scott SM, Dengree RH. Principal investigators and their Associates of Veterans Administration Cooperative Study No. 28. Comparison of medical and surgical treatment for unstable angina pectoris. NEJM 1987; 316: 977-84.
    CrossrefPubMedGoogle Scholar
  • 36 Luscher MS, Thygesen R, Ravkilde J. et al. Applicability of cardiac troponin T and I for the early risk stratification in unstable coronary disease. Circ 1997; 96: 2578-85.
    CrossrefPubMedGoogle Scholar
  • 37 Meinertz T, Hamm CW. Rapid testing for cardiac troponins in patients with acute chest pain in the emergency room. Eur Heart J 1998; 19: 973-4.
    PubMedGoogle Scholar
  • 38 Moreno PR, Bernardi VH, Lopez-Cuellar J. et al. Macrophages, smooth muscle cells, and tissue factor in unstable angina: implications for cell mediated thrombogenecity in acute coronary syndromes. Circ 1996; 94: 3090-7.
    CrossrefPubMedGoogle Scholar
  • 39 Mulcahy R, Al Awadhi AH, de Buitloor M. et al. Natural history and prognosis in unstable angina. Am Heart J 1985; 109: 753-8.
    CrossrefPubMedGoogle Scholar
  • 40 Nademanee K, Intarachot V, Josephson MA. et al. Prognostic significance of silent myocardial ischemia in patients with unstable angina. JACC 1987; 10: 1-9.
    CrossrefPubMedGoogle Scholar
  • 41 Napoli C, Lighori A, Chiasello M, Di Ceso N, Condorelli M, Ambrosio G. New-onset angina preceding acute myocardial infarction is associated with improved contractile recovery after thrombolysis. Eur Heart J 1998; 19: 411-9.
    CrossrefPubMedGoogle Scholar
  • 42 Oler S, Whooly MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. JAMA 1996; 276: 811-5.
    CrossrefPubMedGoogle Scholar
  • 43 The PARAGON Investigators. International, randomized, controlled trial of lamifiban (a platelet GPIIb/IIIa inhibitor), heparin or both in unstable angina. Circ 1998; 97: 2386-95.
    CrossrefPubMedGoogle Scholar
  • 44 Patel DJ, Knight CJ, Holdright DR. et al. Pathophysiology of transient myocardial ischemia in acute coronary syndromes. Characterization by continuous ST-segment monitoring. Circ 1997; 95: 1185-92.
    CrossrefPubMedGoogle Scholar
  • 45 Patel DJ, Knight CJ, Holdright DR, Mulcahy D. et al. Long-term prognosis in unstable angina. The importance of early risk stratification using continuous ST-segment monitoring. Eur Heart J 1998; 19: 240-9.
    CrossrefPubMedGoogle Scholar
  • 46 Patel D, Mulcahy D, Curzen N. et al. Prognostic significance of transient ST-segment changes after coronary artery bypass surgery: A long-term follow-up study. Br Heart J 1993; 70: 337-41.
    CrossrefPubMedGoogle Scholar
  • 47 The PLATELET receptor inhibitor in ischemic syndrome management in patients with limited unstable signs and symptoms. PRISM-plus study investigators. Inhibition of platelet Glyoprotein IIb/IIIa with tirofiban in unstable angina and non-Q-wave myocardial infarction. NEJM 1998; 338: 1488-97.
    CrossrefPubMedGoogle Scholar
  • 48 The PREHOSPITAL management of acute heart attacks. The task force report. Eur Heart J 1998; 19: 1140-64.
    CrossrefPubMedGoogle Scholar
  • 49 The RESTORE Investigators. Effects of platelet GPIIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circ 1997; 96: 1445-53.
    CrossrefPubMedGoogle Scholar
  • 50 The RISC group. Risk of myocardial infarction and death during treatment with low dose aspirin and i.v. heparin in men with unstable coronary diesease. Lancet 1990; 336: 827-30.
    CrossrefPubMedGoogle Scholar
  • 51 Schror K. Antiplatelet drugs. A comparative review. Drugs 1995; 50: 7-28.
    CrossrefPubMedGoogle Scholar
  • 52 Schror K, Breddin HK. Grundlagen der antithrombotischen Wirkung von Acetysalicylsaure. In: ASA im kardiovaskularen System. 1996. Birkhauser Verlag Basel; Switzerland.:
    Google Scholar
  • 53 Theroux P, Fuster V. Acute coronary syndromes. Unstable angina and non-QW myocardial infarction. Circ 1998; 97: 1195-206.
    CrossrefPubMedGoogle Scholar
  • 54 Theroux P, Kouz S, Roy L. et al. On behalf of the Investigators. Platelet membrane receptor Glyoprotein IIb/IIIa antagonism in unstable angina. The Canadian lamifiban study. Circ 1996; 94: 899-905.
    CrossrefPubMedGoogle Scholar
  • 55 Theroux P, Quimet H, McCaus J. et al. Aspirin, heparin, or both to treat acute unstable angina. NEJM 1988; 319: 1105-11.
    CrossrefPubMedGoogle Scholar
  • 56 TIMI III BInvestigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-QW myocardial infarction: results of the TIMI III B trial. Circ 1994; 89: 154-6.
    PubMedGoogle Scholar
  • 57 Toeffler GH, Muller JE, Stone PH, Willich GN, Davis VG, Braunwald E. and the MILIS study group. Factors leading to shorter survival after acute myocardial infarction in patients aged 65 to 75 years compared with younger patients. AJC 1988; 62: 860-7.
    CrossrefPubMedGoogle Scholar
  • 58 Van Domburg RT, van Miltenburg AJ, Veerhoek RJ. et al. Unstable angina: good long-term outcome after a complicated early course. JACC 1998; 31: 1534-9.
    CrossrefPubMedGoogle Scholar
  • 59 The Vet. Affairs non-Qwave infarction strategies in Hospital (VANQWISH) study. Results presented at the European Heart Association meeting. Stockholm. Sweden: August 25 1997
    PubMedGoogle Scholar
  • 60 White HD. on behalf of the platelet receptor inhibition in ischemic syndrome management (PRISM) study Presented at the ACC scientific session. Anaheim. Calif: March 17 1997
    PubMedGoogle Scholar
  • 61 Willard JE, Lange RA, Hillis LD. The use of aspirin in ischemic heart disease. NEJM 1992; 327: 175-81.
    CrossrefPubMedGoogle Scholar
  • 62 Willerson JT, Golino P, Eidt J. et al. Specific platelet mediators und unstable coronary artery lesions: experimental evidence and potential clinical implications. Circ 1989; 80: 198-205.
    CrossrefPubMedGoogle Scholar
  • 63 Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-QW and QW myocardial infarctions. Coron Art Dis 1994; 5: 1009-18.
    CrossrefPubMedGoogle Scholar